Archives of Physical Medicine and Rehabilitation
Volume 90, Issue 9 , Pages 1453-1461 , September 2009

A Preliminary Assessment of the Benefits of the Addition of Botulinum Toxin A to a Conventional Therapy Program on the Function of People With Longstanding Stroke

  • Jay M. Meythaler, MD, JD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Wayne State University School of Medicine, Rehabilitation Institute of Michigan, Detroit MI
    • Corresponding Author InformationCorrespondence to Jay M. Meythaler, MD, JD, Professor, Dept Physical Medicine and Rehabilitation, Wayne State University, School of Medicine, Rm 822 Rehabilitation Institute of Michigan, Detroit, MI 48201
    • ,
  • Laura Vogtle, PhD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, School of Medicine and the University of Alabama at Birmingham, Spain Rehabilitation Center, Birmingham, AL
    • ,
  • Robert C. Brunner, MD

      Affiliations

    • Department of Occupational Therapy, School of Health Professions, University of Alabama at Birmingham, Birmingham, AL

References 

  1. Taub E, Uswatte G, Morris DM. Improved motor recovery after stroke and massive cortical reorganization following constraint-induced movement therapy. Phys Med Rehabil Clin N Am. 2003;14(1 Suppl):S77–S91ix
  2. Taub E, Miller NE, Novack TA, et al. Technique to improve chronic motor deficit after stroke. Arch Phys Med Rehabil. 1993;74:347–354
  3. Taub E, Crago JE, Burgio LD, et al. An operant approach to rehabilitation medicine: overcoming learned nonuse by shaping. J Exp Anal Behav. 1994;61:281–293
  4. van der Lee JH, Wagenaar RC, Lankhorst GJ, Vogelaar TW, Deville WL, Bouter LM. Forced use of the upper extremity in chronic stroke patients: results from a single-blind randomized clinical trial. Stroke. 1999;30:2369–2375
  5. Taub E. Constraint-induced movement therapy and massed practice. Stroke. 2000;31:986–988
  6. Yablon SA. Botulinum neurotoxin intramuscular chemodenervation (Role in the management of spastic hypertonia and related motor disorders). Phys Med Rehabil Clin N Am. 2001;12:833–874vii-viii
  7. Simpson DM. Clinical trials of botulinum toxin in the treatment of spasticity. Muscle Nerve Suppl. 1997;6:S169–S175
  8. Brashear A, Gordon MF, Elovic E, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med. 2002;347:395–400
  9. Wang HC, Hsieh LF, Chi WC, Lou SM. Effect of intramuscular botulinum toxin injection on upper limb spasticity in stroke patients. Am J Phys Med Rehabil. 2002;81:272–278
  10. Bakheit AM, Pittock S, Moore AP, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol. 2001;8:559–565
  11. Bakheit AM, Thilmann AF, Ward AB, et al. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke. 2000;31:2402–2406
  12. Albany K. Physical and occupational therapy considerations in adult patients receiving botulinum toxin injections for spasticity. Muscle Nerve Suppl. 1997;6:S221–S231
  13. Brin MF. Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity (Spasticity Study Group). Muscle Nerve Suppl. 1997;6:S208–S220
  14. Ashworth B. Preliminary Trial of Carisoprodol in Multiple Sclerosis. Practitioner. 1964;192:540–542
  15. Penn RD, Savoy SM, Corcos D, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med. 1989;320:1517–1521
  16. Meythaler JM. Spastic hypertonia (Appendix). Phys Med Rehabil Clin N Am. 2001;12:953–956ix
  17. Wolf SL, Catlin PA, Ellis M, Archer AL, Morgan B, Piacentino A. Assessing Wolf motor function test as outcome measure for research in patients after stroke. Stroke. 2001;32:1635–1639
  18. van der Lee JH, Beckerman H, Knol DL, de Vet HC, Bouter LM. Clinimetric properties of the motor activity log for the assessment of arm use in hemiparetic patients. Stroke. 2004;35:1410–1414
  19. Law M, Usher P. Validation of the Klein-Bell activities of daily living scale for children. Can J Occup Ther. 1988;55:63–68
  20. Mahoney FI, Barthel DW. Functional Evaluation: the Barthel Index. Md State Med J. 1965;14:61–65
  21. McHorney CA, Ware JE, Rogers W, Raczek AE, Lu JF. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts (Results from the Medical Outcomes Study). Med Care. 1992;30(5 Suppl):MS253–MS265
  22. McHorney CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247–263
  23. Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN. Intrathecal baclofen for spastic hypertonia from stroke. Stroke. 2001;32:2099–2109
  24. Bohannon RW. Hand-grip dynamometry provides a valid indication of upper extremity strength impairment in home care patients. J Hand Ther. 1998;11:258–260
  25. Downie WW, Leatham PA, Rhind VM, Wright V, Branco JA, Anderson JA. Studies with pain rating scales. Ann Rheum Dis. 1978;37:378–381
  26. Price DD, Bush FM, Long S, Harkins SW. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain. 1994;56:217–226
  27. Levy CE, Giuffrida C, Richards L, Wu S, Davis S, Nadeau SE. Botulinum toxin A, evidence-based exercise therapy, and constraint-induced movement therapy for upper-limb hemiparesis attributable to stroke: a preliminary study. Am J Phys Med Rehabil. 2007;86:696–706

 Supported by an unrestricted grant to University of Alabama at Birmingham by Allergan Inc. Allergan was allowed to see a prior draft of this article and make comments, but the authors made all decisions regarding the final content.

 A commercial party having a direct financial interest in the results of the research supporting this article has not conferred nor will confer a financial benefit on the author or one or more of the authors.

 Reprints are not available from the author.

PII: S0003-9993(09)00357-8

doi: 10.1016/j.apmr.2009.02.026

Archives of Physical Medicine and Rehabilitation
Volume 90, Issue 9 , Pages 1453-1461 , September 2009

Article Tools

* Image Usage & Resolution